Histone Lysine Lactylation (Kla)‐induced <scp>BCAM</scp> Promotes <scp>OSCC</scp> Progression and Cis‐Platinum Resistance
Kla was identified to be associated with OSCC prognosis, drug therapy, and TME. Histone Kla-induced BCAM was identified to play a crucial role during OSCC progression, suggesting that Kla is promising to be a novel therapeutic target for OSCC.
Authors
- Zhongkai Ma (ORCID: https://orcid.org/0000-0001-7307-1801)
- Grace Paka Lubamba (ORCID: https://orcid.org/0000-0003-2709-0483)
- Su Chen (ORCID: https://orcid.org/0000-0001-7688-9051)
- Honglin Li (ORCID: https://orcid.org/0000-0003-2270-1900)
- Chunjie Li (ORCID: https://orcid.org/0000-0002-7962-1904)
- Zhiyong Guo (ORCID: https://orcid.org/0000-0001-8791-0020)
- Jialu He (ORCID: https://orcid.org/0009-0009-2325-9537)
- Guangzhao Huang (ORCID: https://orcid.org/0009-0009-8306-8353)
- Lei Wang (ORCID: https://orcid.org/0000-0003-0734-7026)
Institutions
- Sichuan University (CN)
- Tibet Autonomous Region People's Hospital (CN)
- State Key Laboratory of Oral Diseases
Publication Details
- Journal
- Oral Diseases
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1111/odi.15179
- Citations
- 8
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.87